Adam Bergin, PhD, is a Principal Scientist at Eli Lilly and Company, specializing in the biopharmaceutical field with extensive knowledge in large molecule drug substance production and upstream processing. They previously worked as a Graduate Upstream Process Scientist at Pfizer and held various roles in Eli Lilly's Technical Services and Manufacturing Sciences department. Adam earned their PhD from University College Dublin and has also completed a Master's in Bioprocess Engineering and a Bachelor's in Biotechnology. Their expertise includes implementing control strategies, ensuring regulatory compliance, and generating essential documentation in GMP environments.
This person is not in any teams
This person is not in any offices